@inproceedings{inproceedings, title  = {{SUNRISE-3: TAR-200 PLUS CETRELIMAB OR TAR-200 VERSUS INTRAVESICAL BACILLUS CALMETTE-GUERIN IN PATIENTS WITH BACILLUS CALMETTE-GUERIN-NAIVE HIGH-RISK NON-MUSCLE-INVASIVE BLADDER CANCER}},

 year = {{2024}},

 month = {{5}},

 author = {{Chang SS and Necchi A and Powles T and Guerrero-Ramos F and Simone G and Shore N and Salinas J and Merseburger AS and Roumiguie M and Kitamura H and Morris D et al}},

 volume = {{211}},

 journal = {{JOURNAL OF UROLOGY}},

 issue = {{5}},

 note = {{Accessed on 2026/11/12}}}